In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, the causative agent of coronavirus disease (COVID-19)) has caused relatively high mortality rates in humans throughout the world since its first detection in late December 2019, leading to the most devastating pandemic of the current centu...

Full description

Bibliographic Details
Main Authors: Mahmoud M. Shehata, Sara H. Mahmoud, Mohammad Tarek, Ahmed A. Al-Karmalawy, Amal Mahmoud, Ahmed Mostafa, Mahmoud M. Elhefnawi, Mohamed A. Ali
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Molecules
Subjects:
SARS-CoV-2
prediction
epitopes
vaccine
Online Access:https://www.mdpi.com/1420-3049/26/20/6182

Internet

https://www.mdpi.com/1420-3049/26/20/6182

Similar Items